Strategic Partnerships Quanticate actively pursues collaborations with specialized tech and CRO partners (e.g., PhaseVtrials for adaptive trial design, KPS Life for FSP). This presents an opportunity to position complementary services and co-sell with PhaseVtrials or KPS Life to expand offerings in adaptive design, monitoring, and operational support.

Adaptive Trial Opportunity Recent news indicates a focus on designing and optimizing adaptive trials using machine learning. Target sponsors planning adaptive or complex trial designs and offer Quanticate’s data management, biostatistics, and centralized monitoring to accelerate design, simulation, and execution.

Real-World Evidence Recognition as a finalist for Real-World Evidence use suggests strength in RWE analytics. Target pharmaceutical and biotech clients seeking RWE in post-market surveillance, comparative effectiveness studies, and safety signal detection to support regulatory submissions.

PV and Safety Quanticate launched and expanded pharmacovigilance capabilities (QVigilance) and has ongoing post-marketing data-management expertise. Sell PV services, safety signal monitoring, and risk management to sponsors with broad pharmacovigilance needs or portfolio products in multiple markets.

Global CRO Footprint As a global data-focused CRO with a broad service mix (DMP, biostatistics, SAS, medical writing, PV), target mid-to-late-stage pharma, biotech, and device companies seeking outsourced data services, especially those looking for integrated data solutions and flexible FSP options.